CD200 <sup>+</sup> cytotoxic T lymphocytes in the tumor microenvironment are crucial for efficacious anti–PD-1/PD-L1 therapy
Xinxin Wang(Handan College), Bo Zhu(Army Medical University), Alistair L. J. Symonds(Queen Mary University of London), Haoran Zha(Army Medical University), Yisong Y. Wan(University of North Carolina at Chapel Hill), Haixia Long(Army Medical University), Qingzhu Jia(Army Medical University), Jianbao Gao(Army Medical University), Ting Yuan(Goethe University Frankfurt), Qi-Jing Li(Agency for Science, Technology and Research), Lujing Wang(Army Medical University), Zhongyu Wang(Army Medical University), Fei Yang(Shanghai Jiao Tong University), Ying Jiang(Huazhong University of Science and Technology), Chunyan Hu(Army Medical University), Wei Wu(Huazhong Agricultural University), Shuanglong Xie(Army Medical University), Anmei Zhang(Army Medical University)
Cited by 34
Related Papers
Small molecules in targeted cancer therapy: advances, challenges, and future perspectives
|Signal Transduction and Targeted Therapy|2021|1.7k
Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression
|Nature|2007|856
New insights into oxidative stress and inflammation during diabetes mellitus-accelerated atherosclerosis
|Redox Biology|2018|753
Clinical characteristics of 82 cases of death from COVID-19
|PLoS ONE|2020|594
Immune Phenotyping Based on the Neutrophil-to-Lymphocyte Ratio and IgG Level Predicts Disease Severity and Outcome for Patients With COVID-19
|Frontiers in Molecular Biosciences|2020|497